% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Cieciera:125646,
author = {M. Cieciera and C. Kratochwil and J. Moltz and H. U.
Kauczor and T. Holland-Letz$^*$ and P. Choyke and W. Mier
and U. Haberkorn$^*$ and F. Giesel$^*$},
title = {{S}emi-automatic 3{D}-volumetry of liver metastases from
neuroendocrine tumors to improve combination therapy with
177{L}u-{DOTATOC} and 90{Y}-{DOTATOC}.},
journal = {Diagnostic and interventional radiology},
volume = {22},
number = {3},
issn = {1305-3612},
address = {Ankara},
reportid = {DKFZ-2017-01772},
pages = {201 - 206},
year = {2016},
abstract = {Patients with neuroendocrine tumors (NET) often present
with disseminated liver metastases and can be treated with a
number of different nuclides or nuclide combinations in
peptide receptor radionuclide therapy (PRRT) depending on
tumor load and lesion diameter. For quantification of
disseminated liver lesions, semi-automatic lesion detection
is helpful to determine tumor burden and tumor diameter in a
time efficient manner. Here, we aimed to evaluate
semi-automated measurement of total metastatic burden for
therapy stratification.Nineteen patients with liver
metastasized NET underwent contrast-enhanced 1.5 T MRI using
gadolinium-ethoxybenzyl diethylenetriaminepentaacetic acid.
Liver metastases (n=1537) were segmented using Fraunhofer
MEVIS Software for three-dimensional (3D) segmentation. All
lesions were stratified according to longest 3D diameter >20
mm or ≤20 mm and relative contribution to tumor load was
used for therapy stratification.Mean count of lesions ≤20
mm was 67.5 and mean count of lesions >20 mm was 13.4.
However, mean contribution to total tumor volume of lesions
≤20 mm was $24\%,$ while contribution of lesions >20 mm
was $76\%.Semi-automatic$ lesion analysis provides useful
information about lesion distribution in predominantly liver
metastasized NET patients prior to PRRT. As conventional
manual lesion measurements are laborious, our study shows
this new approach is more efficient and less
operator-dependent and may prove to be useful in the
decision making process selecting the best combination PRRT
in each patient.},
keywords = {177Lu-octreotide, DOTA(0)-Tyr(3)- (NLM Chemicals) /
90Y-octreotide, DOTA-Tyr(3)- (NLM Chemicals) /
Radiopharmaceuticals (NLM Chemicals) / gadolinium
ethoxybenzyl DTPA (NLM Chemicals) / Gadolinium DTPA (NLM
Chemicals) / Octreotide (NLM Chemicals)},
cin = {C060 / E060},
ddc = {610},
cid = {I:(DE-He78)C060-20160331 / I:(DE-He78)E060-20160331},
pnm = {315 - Imaging and radiooncology (POF3-315)},
pid = {G:(DE-HGF)POF3-315},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:27015320},
pmc = {pmc:PMC4859734},
doi = {10.5152/dir.2015.15304},
url = {https://inrepo02.dkfz.de/record/125646},
}